Santen Pharmaceutical
4536.T
#3202
Rank
NZ$6.43 B
Marketcap
$18.42
Share price
0.15%
Change (1 day)
23.75%
Change (1 year)

Operating Margin for Santen Pharmaceutical (4536.T)

Operating Margin as of November 2024 (TTM): 10.89%

According to Santen Pharmaceutical 's latest financial reports and stock price the company's current Operating Margin is 10.89%. At the end of 2023 the company had an Operating Margin of -1.54%.

Operating Margin history for Santen Pharmaceutical from 2009 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-1.54%-111.14%
202213.83%162.01%
20215.28%-63.02%
202014.28%-27.37%
201919.66%11.38%
201817.65%4.62%
201716.87%-59.31%
201641.46%85.63%
201522.33%6.07%
201421.05%-2.06%
201321.50%-11.56%
201224.31%-13.41%
201128.07%8.33%
201025.92%65.76%
200915.64%-21.44%
200819.90%-5.35%
200721.03%1.25%
200620.77%3.39%
200520.09%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.